Codexis, Inc. (CDXS)
Codexis, Inc. is a biotechnology company specializing in enzyme engineering and development for pharmaceuticals, biofuels, and specialty chemicals. Founded in 2002, the company focuses on creating biocatalysts that enable sustainable manufacturing processes, improving efficiency and reducing environmental impact.
Company News
Codexis, a provider of enzymatic solutions for therapeutics manufacturing, will participate in the Cantor Global Healthcare Conference in New York on September 4, 2025, presenting a live webcast of their fireside chat.
Codexis (CDXS) delivered earnings and revenue surprises of 112.50% and 7.42%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. Helix Energy posted adjusted earnings of 6 cents per share, missing market estimates of 10 cents per share. The company’s quarterly sales came in at $335.16 million versus expectations of $315.60 million. Helix Energy Solut...
Baillie Gifford’s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. Click here for a detailed analysis.
CDXS earnings call for the period ending September 30, 2021.